Checkmate Pharmaceuticals Earnings History image   This CMPI earnings history page last updated 5/16/2022
Checkmate Pharmaceuticals Earnings History Chart
Data adjusted for CMPI split history

PeriodEarnings DateGAAP
Q1 20225/12/2022-0.730
Q4 20213/29/2022-0.620
Q3 202111/12/2021-0.690
Q2 20218/12/2021-0.880
Q1 20215/13/2021-0.650
Q4 20203/29/20211.300
Q3 202011/13/2020-0.840
Q2 20209/18/2020-7.370
Checkmate Pharmaceuticals Revenue History Chart
PeriodEarnings DateGAAP
Q1 20225/12/2022NA
Q4 20213/29/2022NA
Q3 202111/12/2021NA
Q2 20218/12/2021NA
Q1 20215/13/2021NA
Q4 20203/29/2021NA
Q3 202011/13/2020NA
Q2 20209/18/2020NA
Quotes delayed 20 minutes

Email EnvelopeFree CMPI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options

Next Earnings Date Calendar:

Esports Technologies (EBET): 5/16/2022 6:00 AM
Clear Secure (YOU): 5/16/2022 6:30 AM
1847 Goedeker (GOED): 5/16/2022 6:30 AM
Warby Parker (WRBY): 5/16/2022 7:00 AM
Chimerix (CMRX): 5/16/2022 7:00 AM
Benson Hill (BHIL): 5/16/2022 7:00 AM
Brainstorm Cell (BCLI): 5/16/2022 7:00 AM
Passage Bio (PASG): 5/16/2022 7:00 AM
Taysha Gene Therapies (TSHA): 5/16/2022 7:00 AM
HOOKIPA Pharma (HOOK): 5/16/2022 7:00 AM

More from the Next Earnings Dates Calendar

Earnings History:

NorthEast Community (NECB): 5/15/2022 After close
Cryo-Cell International (CCEL): 5/15/2022 After close
Surgepays (SURG): 5/15/2022 After close
Loyalty Ventures (LYLT): 5/15/2022 9:11 AM
Southern States (SSBK): 5/15/2022 8:32 AM
U.S. Century Bank (USCB): 5/15/2022 7:57 AM
FinWise (FINW): 5/15/2022 3:31 AM
Red Cat Holdings (RCAT): 5/14/2022 6:20 AM
Protagenic Therapeutics (PTIX): 5/13/2022 5:00 PM
cbdMD (YCBD): 5/13/2022 After close

More from the Earnings History archive
Checkmate Pharmaceuticals (CMPI) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

CMPX Historical Earnings
CMRX Historical Earnings
CNC Historical Earnings
CNCE Historical Earnings
CNMD Historical Earnings
CNSP Historical Earnings
CNST Historical Earnings
CNTX Historical Earnings
CNVY Historical Earnings
COCP Historical Earnings
On this page we presented the CMPI earnings and revenue history archive for Checkmate Pharmaceuticals, comparing the historical top line revenue performance quarter by quarter, as well as the CMPI earnings per share history. Any self directed investor doing their due diligence on CMPI (or any other given stock) can benefit from researching all of the Checkmate Pharmaceuticals past earnings and revenue results going backwards in time, and to help you with this Checkmate Pharmaceuticals earnings history research, on this page we presented each quarter's resulting numbers in both table and graphical form for easy comparison. Studying these numbers can help an investor by providing important context with which to think about CMPI's next earnings report. In your continued research on Checkmate Pharmaceuticals we hope you will be sure to check out the further links included for earnings surprises as well as next earnings dates for CMPI. Thanks for visiting, and the next time you need to research CMPI earnings history (or the earnings history of another stock), we hope you'll think of our site as your go-to earnings history research resource of choice.

Recommended: Top Ten Hedge Funds Holding OMQS, RGP Insider Buying, SEM Past Earnings.

 

Checkmate Pharmaceuticals Earnings History | www.NextEarningsDate.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in NextEarningsDate.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.